Pulmonary Sarcoid-Like Granulomatosis Induced by Ipilimumab

Grégoire Berthod, Romain Lazor, Igor Letovanec, +6

Journal of Clinical Oncology

Pulmonary PathologyAutoimmune DiseaseLung InflammationImmunologyPulmonary Alveolar Proteinosis +6

Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial

Amandine Legat, Hélène Maby–El Hajjami, Petra Baumgaertner, +15

Clinical Cancer Research

Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 ⁺ T-myeloid cell networks in melanoma

David Barras, Eleonora Ghisoni, Johanna Chiffelle, +42

Science Immunology

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)

Christoph Driessen, Marianne Kraus, Markus Joerger, +14

Haematologica

Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cells

Petra Baumgaertner, Camilla Jandus, Jean‐Paul Rivals, +10

International Journal of Cancer

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)

Khalil Zaman, Beat Thürlimann, Jens Huober, +9

Annals of Oncology

Breast OncologyBone HealthBreast Cancer PatientsMedicineBone Mineral Density +7

The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study

Filipe Martins, Luis Schiappacasse, Marc Levivier, +11

Journal of Neuro-Oncology

Neuro-oncologySurgical OncologyRadiation TherapyMedicineMelanoma +8

ALK-negative anaplastic large cell lymphoma with <i>DUSP22</i> rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study

David Sibon, Bettina Bisig, Christophe Bonnet, +20

Haematologica

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

Felicitas Hitz, Natalie Fischer, Th. Pabst, +6

Annals of Hematology

Hematological MalignancyAnthracycline-based TherapyLymphoid NeoplasiaMedicineImmunology +6

Solitary Choriocarcinoma in the Lung

Grégoire Berthod, Hanifa Bouzourène, Christine Pachinger, +1

Journal of Thoracic Oncology

Surgical PathologyHistopathologyPathologyBronchial NeoplasmSolitary Choriocarcinoma +4